Skip to main content
. 2022 Jun 13;34(6):494–502. doi: 10.1016/j.sdentj.2022.06.002

Table 3.

Comparison of the GI percentage reduction in the Intervention and Placebo groups for all patients, patients with mild, moderate inflammation. Intergroup comparison by Mann-Whitney Test. (Percentage %, Standard Deviation SD).

GI Percentage Reduction
Intervention
Placebo
Interval % SD % SD P-value
All
Patients
Baseline to 30 days 22.33 18.40 12.13 14.39 0.019*
30 to 60 days 10.74 20.17 7.34 15.62 0.395
Baseline to 60 days 33.07 19.01 19.47 16.57 0.005**



Patients
with mild
inflammation
Baseline to 30 days 17.15 17.15 5.57 10.55 0.007**
30 to 60 days 13.13 22.75 9.35 16.17 0.421
Baseline to 60 days 30.28 21.54 14.92 14.61 0.012*



Patients with moderate
inflammation
Baseline to 30 days 34.40 16.03 27.46 9.72 0.122
30 to 60 days 5.17 11.45 2.63 13.95 0.691
Baseline to 60 days 39.57 9.02 30.09 16.75 0.077

*P < 0.05 ** P < 0.01.